• Experienced M&A Advisors
    • Deep Healthcare Industry Expertise
    • Personally Committed
  • Exceed Expectations
    • Strategic
    • Strategic
    • Transaction
    • Transaction
    • Healthcare
    • Healthcare
    • Expertise
    • Expertise
    • Excellence
    • Excellence
    • Experience
    • Experience
    Exceptional Execution
  • We Maximize Value
    • Trusted Advisors
      We seek to earn your confidence and trust. We hold ourselves to the highest standards of ethics and integrity. Our extensive experience allows us to advise you on the most sensitive, critical, complex and value determining strategic initiatives. Your clients, employees, shareholders and families all depend on you. You can depend on us with (and in) confidence.
    • Proven Track Record
      Our senior partners have closed 100+ transactions representing over $30B in total value in their careers. We are experts at achieving the optimal outcome for our clients. We maximize value, securing the highest price on the best possible terms, and in all cases strive to exceed expectations.
    • Extensive Relationship Network
      Our senior partners have 60+ years of combined Investment banking and strategic transaction experience. We have developed an exceptionally broad network of relationships over our careers, which we put to work on your behalf.
    • Healthcare Experts
      Our senior partners have 50+ years of dedicated healthcare experience. Healthcare businesses operate in a unique environment, with complex regulatory, reimbursement and intellectual property considerations. Our dedicated healthcare focus provides us with an unsurpassed depth of understanding and expertise that enables us to achieve the optimal results for our clients.
    • Conflict-Free Representation
      As a private partnership, we are free from the conflicts faced by firms that provide research, trading, represent large corporations or that seek to curry favor with private equity buyers (although we do like curry).
    • Senior Partner Attention
      A senior partner leads each and every one of our transactions from kick-off to closing. This senior level attention assures that our clients receive the highest level of advisory expertise available.
  • We Understandwe are

    Entrepreneurs, Founders, Owners

  • services
    services
    • Mergers and Acquisitions Advisory:
      • Sell-Side Advisory
      • Exclusive sale
      • Private equity recapitalization
      • Corporate divestiture
      • Corporate partnering
      • Leveraged/Management
    • Financings
    • Valuations and Fairness Opinions
    • Pharmaceutical Products Partnering
  • focus
    focus
    • Healthcare Services
    • HIT
    • Physician Services
    • MedTech
    • Pharmaceutical Services
    • Life Sciences
  • clients
    clients
    • Founders
    • Owners
    • Public Companies
    • Entrepreneurs
    • Private companies
    • Investors

Edgemont Capital® Edgemont Capital Partners®
Check the background of this firm on FINRA’s BrokerCheck

Recently
Completed Transactions

Our Principals Have Closed Over 100 Transactions Representing More than $30 billion in Total Value

    Array
    (
        [0] => http://i2.wp.com/www.edgemontcapital.com/wp-content/uploads/2017/10/65-Top.jpg?fit=187%2C140
        [1] => 187
        [2] => 140
    )
    
  • TRANSACTION OVERVIEW
    acquired
    November 2017
    • Evolution Research Group
    • Buy-side Advisory
    • Watchung, NJ
    • Lori Thievon-Wright, Founder & CEO
    • Edgemont Capital Partners acted as exclusive financial advisor to Evolution Research Group in its acquisition of Brain Matters Research
    • Confidential
    • Evolution Research Group is one of the largest independent clinical research site companies in North America
  • Array
    (
        [0] => http://i0.wp.com/www.edgemontcapital.com/wp-content/uploads/2017/08/image.jpg?fit=187%2C140
        [1] => 187
        [2] => 140
    )
    
  • TRANSACTION OVERVIEW
    acquired
    July 2017
    • Evolution Research Group
    • Buy-side Advisory
    • Watchung, NJ
    • Lori Thievon-Wright, Founder & CEO
    • Edgemont Capital Partners acted as exclusive financial advisor to Evolution Research Group in its acquisition of Endeavor Clinical Trials
    • Confidential
    • Evolution Research Group is one of the largest independent clinical research site companies in North America
  • Array
    (
        [0] => http://i0.wp.com/www.edgemontcapital.com/wp-content/uploads/2017/07/63-Top.gif?fit=250%2C75
        [1] => 250
        [2] => 75
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    June 2017
    • Northside Emergency Associates
    • Broad Exclusive Sale
    • Atlanta, GA
    • Dr. Larry Brannam
    • Edgemont Capital Partners acted as exclusive financial advisor to NEA in its sale to Envision
    • Confidential
    • NEA is an emergency services provider to all three Northside Hospital Healthcare System facilities

    Case Study: Northside Emergency Associates

    Edgemont served as the exclusive financial advisor to Northside Emergency Associates (“NEA”) in its sale to Envision Healthcare.

    NEA, established in 1973, provides emergency medicine department management and staffing services to Northside Hospital Healthcare System’s three hospitals in Georgia. With over 65 physicians and advanced practice clinicians staffing three of the busiest emergency departments in Northern Atlanta, NEA provides care to over 170,000 patients a year.

    • Edgemont was retained by NEA in 2016 to advise the partnership on its strategic options after the anesthesia group in NEA’s hospital system was acquired by a national consolidator
    • NEA had held potential sale discussions with some national consolidators in the past, but did not feel that valuations reflected the strength and growth of the practice
    • Edgemont reviewed NEA’s financials and prepared an analysis of the likely synergies and pro-forma income a strategic acquirer would realize after acquiring the company
    • Edgemont’s preliminary valuation work confirmed NEA’s belief that previous offers significantly undervalued NEA
    • Edgemont performed a full analysis of NEA’s strategic and financial options and concluded that an auction process among multiple strategic acquirers was the best direction
    • Edgemont prepared marketing materials highlighting the strength and depth of NEA’s relationship with Northside Hospital and the growth that Northside was experiencing
    • NEA’s leadership and the Edgemont team met with potential strategic bidders at an industry conference to discuss NEA’s practice in detail
    • Edgemont received five initial bids from strategic acquirers in late 2016
    • Edgemont led second-round bidders through a full diligence process and requested final bids in the form of a marked-up purchase contract
      • Competitive final bidding concluded with a sale to Envision Healthcare on very attractive terms
      • NEA and Edgemont achieved a final purchase price significantly higher than the initial round offers

    Edgemont Capital Partners Completes Sale of Northside Emergency Associates to Envision Healthcare

    Acquisition highlights ongoing consolidation in hospital outsourced clinical services; Transaction is Edgemont’s fifth in emergency medicine and eleventh on behalf of hospital-based physician groups

    Edgemont Capital - NEA

    NEW YORK and ATLANTA, July 5, 2017– Edgemont Capital Partners, L.P has acted as exclusive financial advisor to Northside Emergency Associates (“NEA”) in the sale of the company to Envision Healthcare Corp. (NYSE:EVHC).  The transaction closed on June 30, 2017 and was led by Jeff Swearingen, Managing Director, Co-founder of Edgemont, and Head of the Firm’s Physician Services Group, supported by Vitaliy Marchenko, Associate.  Edgemont is the preeminent healthcare-focused middle market investment bank, focused on serving the advisory needs of healthcare providers and entrepreneurs for more than 15 years.

    NEA’s sale continues the trend of hospital outsourced clinical services consolidation, driven by regulatory pressures and most recently the implementation of the Medicare Access and CHIP Reauthorization Act of 2015, and marks the 85th transaction in emergency medicine since 2008. NEA’s more than 65 physicians and advanced practice clinicians staff three of the busiest emergency departments in Northern Atlanta, providing care to over 170,000 patients a year.

    “Edgemont’s deep healthcare industry knowledge and transaction experience gave us confidence that NEA’s shareholders would achieve an outstanding result,” said Dr. Robert Higgins, President Emeritus of NEA. “Jeff’s relentless commitment to physicians and intimate understanding of the emergency medicine business resulted in a great transaction for NEA’s shareholders.”

    Dr. Larry Brannam, President of NEA, said, “Edgemont’s expert advice and guidance throughout the highly competitive sale process gave NEA’s shareholders comfort in knowing that the practice is joining a partner that will provide the resources necessary to serve the patients in our community. We are grateful to the Edgemont team for its expert advice and guidance throughout the sale process.”

    Edgemont’s role as NEA’s exclusive M&A advisor is the firm’s eleventh closed transaction on behalf of hospital-based physician groups and management companies and fifth in Emergency Medicine.  Edgemont has served as exclusive advisor to Emergency Medicine practices and management companies representing over five million annual emergency room visits.  Edgemont previously represented Florida Emergency Physicians in its sale to TeamHealth Holdings Inc.; Premier Emergency Medical Specialists, PLLC in its sale to Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ:AMSG); Premier Physician Services, Inc. (of Dayton, Ohio) in its sale to TeamHealth Holdings Inc.; Practice Support Resources, LLC in its sale to Intermedix Corporation; Milford Anesthesia Associates in its sale to Envision Healthcare Holdings, Inc. (NYSE: EVHC); South Oakland Anesthesia Associates in its sale to MEDNAX, Inc. (NYSE: MD); Wolverine Anesthesia Consultants in its sale to TeamHealth Holdings Inc.; New Jersey Anesthesia Associates in its sale to MEDNAX, Inc.; Anesthesia Services Associates in its sale to PhyMed Management, LLC; and Associated Anesthesiologists of Reno, P.C. in its sale to MEDNAX, Inc.

    “No other investment banking firm has represented more large and mid-sized independent hospital-based physician groups,” said Swearingen.  “Edgemont is the leading investment bank for independent physician groups.  Edgemont’s Physician Services Group serves practices across a broad range of hospital and office-based specialties, including emergency medicine, hospitalist medicine, anesthesia, radiology, dermatology, ophthalmology, urology, urgent care, and occupational medicine.”

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, L.P. (www.edgemontcapital.com) is an independent investment banking firm founded in 2001 to provide the highest quality strategic advisory and capital raising services to healthcare companies.  The firm’s deep healthcare industry knowledge, extensive relationship network and substantial M&A transaction expertise allow Edgemont to address healthcare companies’ strategic and financing needs with great success.  The firm’s principals have closed over 100 healthcare transactions, representing more than $30 billion in value.

    For more information on Edgemont Capital Partners, L.P.’s efforts in Physician Services contact Jeff Swearingen at +1 (212) 867-8938.

    Investment banking services are provided by Edgemont Capital Partners, L.P., a registered broker-dealer and member of FINRA and SIPC.

    ###

    Northside Emergency Associates

    “Edgemont’s deep healthcare industry knowledge and transaction experience gave us confidence that NEA’s shareholders would achieve an outstanding result. Jeff’s relentless commitment to our physicians and intimate understanding of the emergency medicine business resulted in a positive outcome for NEA’s shareholders.”

    Dr. Robert Higgins
    President Emeritus
    Northside Emergency Associates

    “Edgemont’s expert advice and guidance through the highly competitive sale process gave NEA’s shareholders comfort. We are grateful to the Edgemont team for the success of the sale.”

    Dr. Larry Brannam
    President
    Northside Emergency Associates

     

  • Array
    (
        [0] => http://i1.wp.com/www.edgemontcapital.com/wp-content/uploads/2017/03/62-Top.png?fit=250%2C36
        [1] => 250
        [2] => 36
    )
    
  • TRANSACTION OVERVIEW
    recapitalized by
    March 2017
    • Skin and Beauty Center
    • Broad
    • Burbank, CA
    • Dr. Payam Saadat and Dr. Manjunath Vadmal, Partners
    • Edgemont Capital Partners acted as the exclusive financial advisor to SBC in its recapitalization by Gemini Investors
    • Confidential
    • Skin and Beauty Center is the largest full-service cosmetic, medical and surgical dermatology provider in Northern Los Angeles, California

    Case Study: Recapitalization of Skin and Beauty Center

    SBC is the largest and fastest growing dermatology group in northern Los Angeles, California. The Company offers full-service cosmetic, medical and surgical dermatology services.

    • Edgemont acted as exclusive financial advisor to SBC
      • Retained: March 28, 2016
      • Entered into LOI: December 15, 2016
      • LOI to close: 81 days
    • Edgemont ran a broad, competitive process that optimally positioned the Company to extract maximum value for its shareholders
      • Significant interest from both private equity investors as well as strategic acquirers
    • Gemini Investors has plans to rapidly expand the business both organically and through acquisitions

    Edgemont Capital Partners Advises Skin & Beauty Center, Inc. on Recapitalization

    Investment by Gemini Investors positions leading provider of cosmetic, medical, and surgical dermatology services for further growth

    NEW YORK and BURBANK, CA, May 31, 2017 – Edgemont Capital Partners, LP, a leading independent investment banking firm, today announced that it served as exclusive financial advisor to Skin & Beauty Center, Inc. (“SBC”) in its recapitalization by Gemini Investors.  Terms of the deal were not disclosed.

    Founded in 2006 by Dr. Payam Saadat and Dr. Manjunath Vadmal, and headquartered in Burbank, California, Skin & Beauty Center (www.dermla.com) provides high quality medical, surgical and cosmetic dermatology services through five clinics, employing a skilled team of dermatologists, dermatopathologists, estheticians and dermatologic, cosmetic, Mohs and aesthetic surgeons.  The investment by Gemini Investors further cements SBC as the leading dermatology provider in the Los Angeles area, and provides support for an acceleration of the company’s expansion in Los Angeles and surrounding markets.

    Luke J. Mitchell, Managing Director, and leader of Edgemont’s efforts with office-based physician services groups, led the Edgemont engagement team, along with associate Vitaliy Marchenko and analyst Taylor Grant.

    Mr. Mitchell stated, “We are honored to have played a significant role in this transaction and we are confident this will be a very successful partnership between Doctor Saadat, Doctor Vadmal, and Gemini Investors.  The combination of the founders’ vision and passion for delivering excellent clinical care and patient satisfaction, and Gemini Investors’ long track record of supporting high growth companies with strong management teams, will result in one of the leading dermatology services platforms in the country.”

    The recapitalization of SBC is Edgemont’s twelfth closed transaction on behalf of physician groups, clinics and practice management companies. The transaction closed on March 3, 2017.

    About Skin and Beauty Center

    Founded in 2006, Skin & Beauty Center is the largest full-service cosmetic, medical and surgical dermatology provider in Northern Los Angeles, California. More information can be found at www.dermla.com.

    About Gemini Investors

    Founded in 1993, Gemini Investors is a Massachusetts-based investor in lower middle market companies. Since its inception, it has invested over $550 million in companies throughout the U.S. The firm is currently investing Gemini Investors VI, L.P.

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, L.P. (www.edgemontcapital.com) is an independent investment banking firm founded in 2001 to provide the highest quality strategic advisory and capital raising services to healthcare companies.  The firm’s deep healthcare industry knowledge, extensive relationship network and substantial transaction expertise allow Edgemont to address healthcare companies’ strategic and financing needs with great success.  The firm’s principals have closed over 100 healthcare transactions, representing more than $30 billion in value.

    For more information on Edgemont Capital Partners, L.P.’s efforts in office-based physician services contact Luke J. Mitchell at +1 (212) 867-5181.

    Investment banking services are provided by Edgemont Capital Partners, L.P., a registered broker-dealer and member of FINRA and SIPC.

  • Array
    (
        [0] => http://i1.wp.com/www.edgemontcapital.com/wp-content/uploads/2016/10/58-Top.png?fit=250%2C44
        [1] => 250
        [2] => 44
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    October 2016
    • Florida Emergency Physicians
    • Broad Exclusive Sale
    • Orlando, FL
    • Dr. Jorge Lopez, CEO
    • Edgemont Capital Partners acted as exclusive financial advisor to FEP in its sale to TeamHealth
    • Confidential
    • FEP is the emergency medicine services provider to Florida Hospital throughout the greater Orlando region, providing services at 11 hospitals

    Edgemont Capital Partners Completes Sale of Florida Emergency Physicians to TeamHealth

    Leading independent healthcare investment banking firm serves as exclusive financial advisor to FEP, the largest independent Emergency Medicine physician group in Florida

    NEW YORK and ORLANDO, October 3, 2016 — Edgemont Capital Partners, L.P., a leading independent healthcare investment banking firm providing merger and acquisition advisory services to healthcare companies, today announced that it acted as exclusive financial advisor to Florida Emergency Physicians Kang & Associates, M.D., Inc. (“FEP”) in the sale of the company to TeamHealth Holdings Inc. (NYSE: TMH).  The transaction closed on October 1, 2016 and was led by Jeff Swearingen, Managing Director, Co-founder of Edgemont, and Head of the Firm’s Physician Services Group and Luke Mitchell, Managing Director.

    Based in Orlando, Florida, FEP is the exclusive emergency medicine staffing provider for 11 facilities spanning five counties within the Florida Hospital health system. FEP comprises approximately 150 physicians and 100 advanced practice clinicians who provide care for 600,000 patients each year.  FEP is the largest independent Emergency Medicine physician group in the state of Florida and has served the Florida Hospital system for over 45 years.

    “Right from the start, Jeff and the Edgemont team demonstrated a strong understanding of the Emergency Medicine business and a real commitment to providing great service and the right advice,” said Dr. Jorge Lopez, Chief Executive Officer of FEP.  “Edgemont’s market insight and strong execution resulted in a great transaction for FEP’s shareholders, with a partner that will provide the tools and resources to better serve the emergency medicine needs of Orlando.  We are grateful to the Edgemont team for its expert advice and guidance throughout the sale process.  Edgemont’s professionalism and dedication to this engagement, and the depth of its industry experience resulted in a competitive process that brought us an outstanding partner.”

    Edgemont’s role as FEP’s exclusive advisor is the firm’s tenth closed transaction on behalf of hospital-based physician groups and management companies and fourth in Emergency Medicine.  Edgemont has now served as exclusive advisor to Emergency Medicine practices and management companies representing over 5 million annual emergency room visits.  Edgemont previously represented Premier Emergency Medical Specialists, PLLC in its sale to Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ:AMSG); Premier Physician Services, Inc. (of Dayton, Ohio) in its sale to TeamHealth Holdings Inc.; Practice Support Resources, LLC in its sale to Intermedix Corporation; Milford Anesthesia Associates in its sale to Envision Healthcare Holdings, Inc. (NYSE: EVHC); South Oakland Anesthesia Associates in its sale to MEDNAX, Inc. (NYSE: MD); Wolverine Anesthesia Consultants in its sale to TeamHealth Holdings Inc.; New Jersey Anesthesia Associates in its sale to MEDNAX, Inc.; Anesthesia Services Associates in its sale to PhyMed Management, LLC; and Associated Anesthesiologists of Reno, P.C. in its sale to MEDNAX, Inc.

    “Independent, high quality physician practices of scale are seeking the highest level of quality and experience in the financial advisors they hire.  Edgemont is unsurpassed in its track record of achieving the best transaction outcomes for its independent physician practice clients,” added Mr. Swearingen.  “No other investment banking firm has represented more large and mid-sized independent hospital-based physician groups in sale transactions, and Edgemont is the only investment bank that has represented independent groups in sale transactions with all of the publicly-traded hospital-based specialty providers, including EmCare, MEDNAX, Sheridan and TeamHealth.”

    Associate Reid Petersen and two Analysts completed the Edgemont transaction team.  Brent Hill and Amanda Jester of Waller Lansden Dortch & Davis, LLP served as legal counsel to FEP.

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, L.P. (www.edgemontcapital.com) is an independent investment banking firm founded in 2001 to provide the highest quality strategic advisory and capital raising services to healthcare companies.  The firm’s deep healthcare industry knowledge, extensive relationship network and substantial transaction expertise allow Edgemont to address healthcare companies’ strategic and financing needs with great success.  The firm’s principals have closed over 100 healthcare transactions, representing more than $30 billion in value.

    For more information on Edgemont Capital Partners, L.P.’s efforts in Physician Services contact Jeff Swearingen at +1 (212) 867-8938.

    Investment banking services are provided by Edgemont Capital Partners, L.P., a registered broker-dealer and member of FINRA and SIPC.

    Florida Emergency Physicians

    “Right from the start, Jeff and the Edgemont team demonstrated a strong understanding of the Emergency Medicine business and a real commitment to providing great service and the right advice. Edgemont’s market insight and strong execution resulted in a great transaction for FEP’s shareholders, with a partner that will provide the tools and resources to better serve the emergency medicine needs of Orlando.  We are grateful to the Edgemont team for its expert advice and guidance throughout the sale process.  Edgemont’s professionalism and dedication to this engagement, and the depth of its industry experience resulted in a competitive process that brought us an outstanding partner.”

    Dr. Jorge Lopez
    CEO
    Florida Emergency Physicians 

  • Array
    (
        [0] => http://i0.wp.com/www.edgemontcapital.com/wp-content/uploads/2016/08/57-Top.png?fit=250%2C96
        [1] => 250
        [2] => 96
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    August 2016
    • Associated Anesthesiologists of Reno
    • Broad Exclusive Sale
    • Reno, NV
    • Dr. Matthew Hoberg / Partnership
    • Edgemont Capital Partners acted as exclusive financial advisor to AAR in its sale to MEDNAX
    • Confidential
    • AAR is the largest anesthesia practice in Northern Nevada and is the exclusive provider at Renown Regional Medical Center, an 808 bed facility, a level 2 Trauma Center, and Northern Nevada Medical Center, Carson Valley Medical Center and various ambulatory surgical centers throughout the region

    Edgemont Capital Partners Completes Sale of Associated Anesthesiologists of Reno to MEDNAX

    Leading independent healthcare investment banking firm serves as exclusive financial advisor to AAR, the largest Anesthesia provider in Northern Nevada

    NEW YORK and RENO, August 8, 2016 — Edgemont Capital Partners, L.P., a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it acted as exclusive financial advisor to Associated Anesthesiologists of Reno, P.C. (“AAR”) in the sale of the company to MEDNAX, Inc. (NYSE: MD).  The transaction closed on August 5, 2016 and was led by Jeff Swearingen, Managing Director, Co-founder of Edgemont, and Head of the Firm’s Physician Services Group.

    Established in 1949, Associated Anesthesiologists of Reno is the largest anesthesia practice in Northern Nevada. The practice provides anesthesia care across a wide spectrum of subspecialty areas, including orthopedic, critical care, obstetric, pediatric and cardiac, and trauma as well as acute pain services. Associated Anesthesiologists of Reno employs 56 full time-anesthesiologists and is the exclusive provider of services to Renown Regional Medical Center, an 808-bed facility, a level 2 Trauma Center, and the only children’s hospital and emergency room in the region. The practice also provides services to Northern Nevada Medical Center, Carson Valley Medical Center and various ambulatory surgical centers throughout the area.

    “We wanted to join a national organization that truly understands the importance of hospital partnerships, and one whose culture and commitment to delivering the highest quality patient care parallels our own,” said Matthew Hoberg, M.D., AAR’s current President and CEO. “We developed a relationship with Jeff and the Edgemont team several years before embarking on this sale process and their expert advice and industry insights in the years leading up to and throughout the transaction resulted in a very competitive sale process that brought us an outstanding partner and a fantastic outcome for AAR,” Dr. Hoberg added. “Edgemont served AAR as a true trusted advisor.”

    Mr. Swearingen said, “Physician practice consolidation remains at the record levels we saw in 2015 as the rollout of the Patient Protection and Affordable Care Act (“ACA”) and the Medicare Access and CHIP Reauthorization Act (“Macra”) continue to create upheaval, increased complexity, and reimbursement uncertainty in the provision of healthcare services.  This environment has led many anesthesia and other hospital-based specialty practices to sell or merge their practices into larger organizations that offer more management depth, access to capital, greater financial stability and other expertise to support physician practices.  We believe this trend will continue as we are in the early stages of the reshaping of the provision of and reimbursement for healthcare.”

    Edgemont’s role as AAR’s exclusive advisor is the firm’s ninth closed transaction on behalf of hospital-based physician groups and management companies and sixth Anesthesia services provider.  Edgemont, a healthcare investment bank, has now served as exclusive advisor to anesthesia practices and management companies that account for approximately 500,000 annual cases. Edgemont previously represented Milford Anesthesia Associates in its sale to Envision Healthcare Holdings, Inc. (NYSE: EVHC); South Oakland Anesthesia Associates in its sale to MEDNAX, Inc. (NYSE: MD); Wolverine Anesthesia Consultants in its sale to TeamHealth Holdings Inc.; New Jersey Anesthesia Associates in its sale to MEDNAX, Inc.; Anesthesia Services Associates in its sale to PhyMed Management, LLC; Premier Emergency Medical Specialists, PLLC (“PEMS”) in its sale to Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ:AMSG); Premier Physician Services, Inc. (of Dayton, Ohio) in its sale to TeamHealth Holdings Inc. (NYSE: TMH); and Practice Support Resources, LLC in its sale to Intermedix Corporation.

    “Independent, high quality physician practices of scale are seeking the highest level of quality and experience in the financial advisors they hire.  Edgemont is unsurpassed in its track record of achieving the best transaction outcomes for our independent physician practice clients,” added Mr. Swearingen.  “No other investment banking firm has represented more large and mid-sized independent anesthesia groups in sale transactions and Edgemont is the only investment bank that has represented independent groups in sale transactions with all of the publicly-traded hospital-based specialty providers, including EmCare, MEDNAX, Sheridan and TeamHealth.”

    Associate, Vitaliy Marchenko, and two of the firm’s analysts completed the Edgemont transaction team.  Brent Hill and Amanda Jester of Waller Lansden Dortch & Davis, LLP served as legal counsel to AAR.

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, L.P. (www.edgemontcapital.com) is an independent investment banking firm founded in 2001 to provide the founders, physicians, and entrepreneurs who represent the cornerstones of healthcare provider services the highest quality strategic advisory and capital raising services.  The firm’s deep healthcare industry knowledge, extensive relationship network and substantial transaction expertise allows Edgemont to address healthcare companies’ strategic and financing needs with great success. The firm’s principals have closed over 100 healthcare transactions, representing more than $30 billion in value.

    For more information on Edgemont Capital Partners, L.P.’s efforts in Physician Services contact Jeff Swearingen at +1 (212) 867-8938.

    Investment banking services are provided by Edgemont Capital Partners, L.P., a registered broker-dealer and member of FINRA and SIPC.

    Associated Anesthesiologists of Reno

    “We wanted to join a national organization that truly understands the importance of hospital partnerships, and one whose culture and commitment to delivering the highest quality patient care parallels our own. We developed a relationship with Jeff and the Edgemont team several years before embarking on this sale process and their expert advice and industry insights in the years leading up to and throughout the transaction resulted in a very competitive sale process that brought us an outstanding partner and a fantastic outcome for AAR. Edgemont served AAR as a true trusted advisor.”

    Dr. Matthew Hoberg
    CEO
    Associated Anesthesiologists of Reno

  • Array
    (
        [0] => http://i1.wp.com/www.edgemontcapital.com/wp-content/uploads/2016/07/56-Top.png?fit=250%2C68
        [1] => 250
        [2] => 68
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    July 2016
    • Compass Research
    • Broad Exclusive Sale
    • Orlando, FL
    • Sean Stanton, CEO; Ownership: Sean Stanton and Craig Curtis, MD
    • Edgemont Capital Partners acted as exclusive financial advisor to Compass Research in the sale of the Company to Bioclinica
    • Confidential
    • Compass Research is the leading neurology clinical research site services company

    Case Study: Compass Research

    Compass Research is the leading clinical research site services company focused on neurology, and conducts studies in a range of other therapeutic areas

    • Edgemont retained in January 2016 to explore sale of the Company
    • Edgemont conducted a competitive auction process broadly marketed to strategic and financial buyers
    • Transaction announced July 25, 2016
      • Founded in 2006, Compass grew over a 10-year period to become the leading independent research site company focused in neuroscience. The principals desired to accelerate their growth and to build a larger geographic presence. They also sought to de-risk this growth strategy. Edgemont approached a broad buyer universe, given rapidly evolving buyer universe interest. The Company attracted strong buyer interest based on its strong neurology presence, overall scale and growth potential, in addition to its scale for a site company. Compass selected Bioclinica as its transaction partner based on its synergistic fit with its existing businesses, role post-transaction, and valuation. Bioclinica’s interest was motivated by its desire to expand its network to North America and gain a foothold in the U.S.

    Edgemont Capital Partners Completes Sale of Compass Research to Bioclinica

    Edgemont Capital acted as exclusive financial advisor to Compass Research in its sale to Bioclinica

    NEW YORK & ORLANDO, Fla.–(BUSINESS WIRE)–Edgemont Capital Partners, a leading independent healthcare investment banking firm, today announced that it served as exclusive financial advisor to Compass Research, LLC in the company’s sale to Bioclinica announced on July 25, 2016.

    Compass Research, a leading provider of neuroscience drug development clinical research services, focuses on conducting Phase I-IV clinical trials in central nervous system (CNS) disorders, as well as other therapeutic areas. The Compass Research transaction team was led by David Blume, Managing Director and Head of Edgemont’s Pharmaceutical Services Group, Reid Petersen, an Associate with Edgemont, and Jay Moon, an Analyst with the firm. The sale of Compass Research is the 13th clinical research site company transaction closed by Edgemont, and the 12th transaction for a CNS focused outsourced pharmaceutical services company.

    “The highly fragmented clinical research site services market is consolidating rapidly. Leading companies in the industry, particularly those with strong clinical and therapeutic expertise such as Compass Research, are in increasingly high demand by a growing number of strategic and financial buyers. These acquirers are seeking to capitalize on benefits of scale for site services given evolving clinical trials business dynamics and in order to address the acute challenges of subject recruitment. As a result, we expect industry consolidation to accelerate,” said Blume.

    Founded in 2006, Compass Research conducts early and late stage clinical research studies for global and mid-sized pharmaceutical and biotech sponsors, as well as leading Contract Research Organizations (CROs), in its state-of-the-art research facilities and clinical pharmacology units located in Orlando, the Villages and Melbourne, all in Florida. The Company is a leading neuroscience research site services company, and also performs studies in a broad range of other indications.

    “We selected Edgemont as our advisor based on their unparalleled M&A expertise in the clinical research services industry and extensive experience advising companies focused on CNS drug development services. Their industry knowledge and transaction expertise were an ideal fit with our strategic needs. We appreciate Edgemont’s commitment to our Company in the sale process. They proved to be a trusted and immensely valuable advisor. Their efforts resulted in a highly successful transaction with an exceptional partner for our Company in Bioclinica,” said Sean Stanton, CEO of Compass Research.

    About Bioclinica

    Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologies. The Medical Imaging and Biomarkers segment provides medical imaging and cardiac safety services and includes a molecular marker laboratory. The eHealth Solutions segment comprises the eClinical Solutions platform; Clinverse Financial Lifecycle Solutions; Safety and Regulatory Solutions; Strategic Consulting Services; App xChange Alliances; and eHealth Cloud Services. Under the Global Clinical Research segment, Bioclinica offers a network of research sites, patient recruitment-retention services, and a post-approval research division. The Company serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia. Learn more at www.bioclinica.com.

    About Edgemont Capital Partners

    Edgemont Capital Partners is a leading independent investment banking firm focused on the merger and acquisitions advisory and financing needs of healthcare companies. Edgemont’s deep healthcare industry knowledge and extensive transaction expertise supports the firm’s unsurpassed ability to address healthcare companies’ strategic advisory (M&A) and financing needs with great success. Edgemont provides sell-side and acquisition advisory, restructuring advisory, board advisory and private placement services.

    For more information on Edgemont Capital Partners Pharmaceutical Services expertise contact David Blume at +1 (212) 867-8937 and see www.edgemontcapital.com.

    Investment banking services are provided by Edgemont Capital Partners, LP, a registered broker-dealer and member of FINRA and SIPC.

    Contacts

    Edgemont Capital Partners
    David Blume, +1 212-867-8937

     

    Compass Research

    “We selected Edgemont as our advisor based on their unparalleled M&A expertise in the clinical research services industry and extensive experience advising companies focused on CNS drug development services. Their industry knowledge and transaction expertise were an ideal fit with our strategic needs. We appreciate Edgemont’s commitment to our Company in the sale process. They proved to be a trusted and immensely valuable advisor. Their efforts resulted in a highly successful transaction with an exceptional partner for our Company in Bioclinica.”

    Sean Stanton
    CEO
    Compass Research

     

  • Array
    (
        [0] => http://i2.wp.com/www.edgemontcapital.com/wp-content/uploads/2015/12/55-Top.png?fit=194%2C90
        [1] => 194
        [2] => 90
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    December 2015
    • Premier Emergency Medical Specialists
    • Limited Exclusive Sale
    • Chandler, AZ
    • Dr. Evan Leibner, CEO
    • Edgemont Capital Partners acted as exclusive financial advisor to PEMS in its sale to Sheridan Healthcare, the Physician Services division of AmSurg Corp.
    • Confidential
    • PEMS provides emergency medicine staffing for two Dignity Health system facilities in the Phoenix metropolitan area

    Case Study: Premier Emergency Medical Specialists

    Edgemont served as the exclusive financial advisor to Premier Emergency Medical Specialists (“PEMS”) in its sale to Sheridan

    • PEMS had established a very solid presence within the Dignity Health system in the greater Phoenix market
    • PEMS’ leadership felt resource challenged in responding to Dignity’s requests to provide emergency medicine staffing at additional Dignity facilities
    • Significant HOCS mergers and acquisitions were occurring in Phoenix, reshaping hospital alignment and relationships
      • Emergency Medicine
      • Hospital Medicine
      • Anesthesia
    • PEMS had been approached and received an offer from a private equity-backed rollup, which offered significant equity and contingent value
    • PEMS retained Edgemont in February 2015 to explore and advise the company on a strategic sale process including the existing offer
    • Edgemont prepared an information packet, contacted strategic buyers and generated five written initial offers
    • PEMS met with three groups and proceeded into detailed due diligence, culminating in multiple final bids with valuations well in excess of initial offers
    • PEMS closed with Sheridan in December 2015 on a very favorable valuation and terms

    Edgemont Capital Partners Completes Sale of Premier Emergency Medical Specialists to Sheridan

    Healthcare investment banking firm serves as exclusive financial advisor to PEMS, one of the leading independent Emergency Medicine physician groups in Arizona

    NEW YORK and PHOENIX, December 7, 2015 — Edgemont Capital Partners, L.P., a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it has acted as exclusive financial advisor to Premier Emergency Medical Specialists, PLLC (“PEMS”) in its sale to Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ:AMSG).  The transaction closed on December 4, 2015 and was led by Edgemont managing directors Jeff Swearingen and Luke Mitchell.

    Mr. Swearingen, co-founder of Edgemont, and head of the firm’s Physician Services Group, said, “We continue to see substantial interest in consolidation across multiple physician specialties, driven by the changing economics of the healthcare industry.  While 2015 has been a very active year for both buyers and sellers, the market dynamics suggest that this trend is likely to continue going into 2016 and beyond.”

    Mr. Mitchell, partner at Edgemont, and leader of the firm’s office-based Physician Services initiatives, added, “The acquisition of PEMS by Sheridan is the kind of high quality transaction that creates substantial benefits for both parties.  We were delighted to have the opportunity to work with these two outstanding management teams in order to make this transaction a reality.”

    PEMS was established in 2003 and provides emergency medicine staffing for two Dignity Health system facilities in the Phoenix metropolitan area: Chandler Regional Medical Center and Mercy Gilbert Medical Center.  PEMS’s more than 50 physicians and advanced practice clinicians care for over 120,000 patients annually, and PEMS is consistently ranked as one of the highest performing emergency medicine groups within the entire multi-state Dignity Health system.

    Dr. Evan Leibner, President and Chief Executive Officer of PEMS commented, “The close of this transaction, and the beginning of our partnership with Sheridan, is a tremendous outcome for our shareholders, all of our clinicians, our partners at Dignity, and the patients and communities we serve.  The combination of PEMS’ exceptional emergency medicine clinical care and Sheridan’s operational, IT, and financial systems and best practices, will ensure that together we are able to continue to be leaders in improving emergency medicine, not just in Arizona, but the entire region.”

    Dr. Leibner continued, “We are grateful to the Edgemont team for their expert advice and guidance throughout the sale process.  Their professionalism and dedication to this engagement, and the depth of their industry experience, resulted in a competitive process that brought us an outstanding partner.”

    The sale of PEMS represents Edgemont’s eighth closed transaction on behalf of hospital-based physician groups and management companies, and third in emergency medicine.  Edgemont previously represented Premier Physician Services, Inc. (of Dayton, Ohio) in its sale to TeamHealth Holdings Inc. (NYSE: TMH), Practice Support Resources, LLC in its sale to Intermedix Corporation, Milford Anesthesia Associates in its sale to Envision Healthcare Holdings, Inc. (NYSE: EVHC); South Oakland Anesthesia Associates in its sale to MEDNAX, Inc. (NYSE: MD); Wolverine Anesthesia Consultants in its sale to TeamHealth Holdings Inc.; New Jersey Anesthesia Associates in its sale to MEDNAX, Inc.; and Anesthesia Services Associates in its sale to PhyMed Management, LLC

    Associate Vitaliy Marchenko and Analyst Yaffet Menna completed the Edgemont transaction team.  Terry Roman, partner at Snell & Wilmer, and Brad Martorana, counsel, served as legal counsel to PEMS.

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, L.P. (www.edgemontcapital.com) is a specialty M&A advisory firm dedicated to providing the highest quality strategic advisory and capital raising services to healthcare companies.  The firm’s deep healthcare industry knowledge, extensive relationship network and substantial transaction expertise allows Edgemont to address healthcare companies’ strategic and financing needs with great success. Edgemont Capital Partners, L.P. provides sell-side and acquisition advisory, restructuring advisory, board advisory and private placement services.

    For more information on Edgemont Capital Partners, L.P.’s efforts in Physician Services contact Jeff Swearingen at +1 (212) 867-8938.

    Investment banking services are provided by Edgemont Capital Partners, L.P., a registered broker-dealer and member of FINRA and SIPC.

    Premier Emergency Medical Specialists

    “We are grateful to the Edgemont team for their expert advice and guidance throughout the sale process.  Their professionalism and dedication to this engagement, and the depth of their industry experience, resulted in a competitive process that brought us an outstanding partner.”

    Dr. Evan Leibner
    CEO
    Premier Emergency Medical Specialists

     

Contact Us